1. Metabolomic-derived endotypes of age-related macular degeneration (AMD): a step towards identification of disease subgroups.
- Author
-
Mendez K, Lains I, Kelly RS, Gil J, Silva R, Miller J, Vavvas DG, Kim I, Miller J, Liang L, Lasky-Su JA, and Husain D
- Subjects
- Humans, Male, Female, Aged, Aged, 80 and over, Cohort Studies, Portugal, Middle Aged, Metabolome, Macular Degeneration metabolism, Macular Degeneration pathology, Metabolomics methods
- Abstract
Age-related macular degeneration (AMD) is a leading cause of blindness worldwide, with a complex pathophysiology and phenotypic diversity. Here, we apply Similarity Network Fusion (SNF) to cluster AMD patients into putative metabolomics-derived endotypes. Using a discovery cohort of 163 AMD patients from Boston, US, and a validation cohort of 214 patients from Coimbra, Portugal, we identified four distinct metabolomics-derived endotypes with varying retinal structural and functional characteristics, confirmed across both cohorts. Patients clustered into Endotype 1 exhibited a milder form of AMD and were characterized by low levels of amino acids in specific metabolic pathways. Meanwhile, patients clustered into both Endotype 3 and 4 were associated with more severe AMD and exhibited low levels of fatty acid metabolites and elevated levels of sphingomyelins and fatty acid metabolites, respectively. These preliminary findings indicate that metabolomics-derived endotyping may offer a refined strategy for categorizing AMD patients based on their specific pathophysiological underpinnings, rather than relying solely on traditional observational clinical indicators., (© 2024. The Author(s).)
- Published
- 2024
- Full Text
- View/download PDF